Astellas Home page | Astellas Pharma Inc.
网页3 天之前 · Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
Home | Astellas Pharma US, Inc.
网页Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company.
Careers at Astellas | Astellas Pharma Inc.
网页Developing innovative therapies is one of the most challenging, most essential and personally rewarding fields in science. Everything we do is led by our company values of integrity, being patient centric, taking ownership, delivering results and …
At a Glance | Astellas Pharma Inc.
网页Of the many R&D programs Astellas has underway, 22 are related to our Rx (prescription drug) business. We also advance Rx+ ® business, which aims to contribute to patients across the whole patient journey (overall medical care, including diagnostic, preventive, therapeutic and prognostic care).
About | Astellas Pharma Inc.
网页Astellas aims to stand on the forefront of healthcare change, turning innovative science into VALUE for patients and will continually strive to fulfill the expectations of our stakeholders and society. Read more.
US Products | Astellas Pharma US | About
网页Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow.
Main Products | Astellas Pharma Inc.
网页Products listed on this website are the main products that Astellas provides globally. These products may not be available in all countries or regions and may be available under different brand names and trademarks, for different indications and patient populations, in different dosages, and in different strengths.
Home | Astellas Pharma Ltd
网页Official website for Astellas Pharma EMEA. Learn about Corporate Information, Research & Development and Corporate Social Responsibility (CSR).
Major Pipeline | Astellas Pharma Inc.
网页The list shows the development status in the target diseases for which we aim to obtain approval in Japan, the United States, Europe and/or China (updated on a quarterly basis).
News | Astellas Pharma Inc.
网页2024年8月28日 · News. European Commission Approves Astellas’ PADCEV TM (enfortumab vedotin) in Combination with KEYTRUDA ® (pembrolizumab) for First-Line Treatment of Advanced Urothelial Cancer. Important Notice. This website contains information about products that may not be available in all countries, or may be available …